Search results
US Government to Fund up to $500 Million for Studies on Oral, Nasal COVID Vaccines
US News & World Report· 4 hours agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
San Francisco Chronicle· 1 day agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
WSB Radio· 1 day agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 15 hours agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Moderna's next-gen COVID vaccine shows non-inferiority to its current shot
Reuters· 15 hours agoThe company has been working on multiple new messenger RNA vaccines, including the recently approved...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
Boston Herald· 1 day agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
ABC News· 1 day agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
Moderna’s next-gen COVID vaccine shows non-inferiority to its current shot
WSAU Wausau· 15 hours ago(Reuters) -Moderna said on Thursday its next-generation COVID-19 vaccine candidate met its main goal...